Michael Gelband’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Michael Gelband's BMY Position: Q2 2026 in Review
Michael Gelband increased its Bristol-Myers Squibb (BMY) stake by 130% in Q2 2026, buying an estimated $8.24M and bringing the position to 253,748 shares worth $14.6M. The position accounts for 0.09% of the portfolio, ranked #200.
Michael Gelband first reported a position in BMY in Q4 2018 and has held it in 20 quarters since. The position peaked at $41.9M in Q1 2023. 2,506 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Michael Gelband held 253,748 shares of Bristol-Myers Squibb worth $14.6M as of Q2 2026.
- Michael Gelband bought 143,563 Bristol-Myers Squibb shares in Q2 2026, an estimated $8.24M.
- Bristol-Myers Squibb made up 0.09% of Michael Gelband's portfolio in Q2 2026, its #200 holding.
- Michael Gelband first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 20 quarters since.
- Michael Gelband's Bristol-Myers Squibb position peaked at $41.9M in Q1 2023.
- 2,506 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.